Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Le Deley

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Statistics in Medicine|February 26, 2011
Dose-finding approach for dose escalation with overdose control considering incomplete observationsA Mauguen, M C Le Deley, S Zohar
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|September 14, 2000
[Parents' opinions of pediatric oncology day hospitals]D Oppenheim, M C Le Deley, F Pein, et al.
Computer Methods and Programs in Biomedicine|July 12, 2011
SAE: an R package for early stopping rules in clinical trialsC Bascoul-Mollevi, A Laplanche, M C Le Deley, et al.
Contemporary Clinical Trials|April 24, 2012
Dose-finding designs in pediatric phase I clinical trials: comparison by simulations in a realistic timeline frameworkA Doussau, B Asselain, M C Le Deley, et al.
Bone Marrow Transplantation|August 1, 1996
Previous conventional chemotherapy is the principal risk factor for immunoglobulin deficiency during the early post-ABMT period in childrenJ Grill, M C Le Deley, D Valteau-Couanet, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Concomitant proton pump inhibitors and capecitabine-based chemoradiotherapy in rectal cancer: an ancillary study from the PRODIGE 23 trialM Bridoux, E Aymes, T Conroy, et al.
ESMO Open|April 5, 2021
Rationale and study design of the CHIPPI-1808 trial: a phase III randomized clinical trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) for stage III ovarian cancer patients treated with primary or interval cytoreductive surgeryHoussein El Hajj, M Vanseymortier, D Hudry, et al.
BMC Medical Informatics and Decision Making|June 26, 2020
GUIP1: a R package for dose escalation strategies in phase I cancer clinical trialsD Dinart, J Fraisse, D Tosi, et al.
Blood|December 1, 1993
Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 GroupP Fenaux, M C Le Deley, S Castaigne, et al.
Gynecologic Oncology|June 2, 2016
Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancerS Gouy, G Ferron, O Glehen, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Statistics in Medicine|February 26, 2011
Dose-finding approach for dose escalation with overdose control considering incomplete observationsA Mauguen, M C Le Deley, S Zohar
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|September 14, 2000
[Parents' opinions of pediatric oncology day hospitals]D Oppenheim, M C Le Deley, F Pein, et al.
Computer Methods and Programs in Biomedicine|July 12, 2011
SAE: an R package for early stopping rules in clinical trialsC Bascoul-Mollevi, A Laplanche, M C Le Deley, et al.
Contemporary Clinical Trials|April 24, 2012
Dose-finding designs in pediatric phase I clinical trials: comparison by simulations in a realistic timeline frameworkA Doussau, B Asselain, M C Le Deley, et al.
Bone Marrow Transplantation|August 1, 1996
Previous conventional chemotherapy is the principal risk factor for immunoglobulin deficiency during the early post-ABMT period in childrenJ Grill, M C Le Deley, D Valteau-Couanet, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Concomitant proton pump inhibitors and capecitabine-based chemoradiotherapy in rectal cancer: an ancillary study from the PRODIGE 23 trialM Bridoux, E Aymes, T Conroy, et al.
ESMO Open|April 5, 2021
Rationale and study design of the CHIPPI-1808 trial: a phase III randomized clinical trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) for stage III ovarian cancer patients treated with primary or interval cytoreductive surgeryHoussein El Hajj, M Vanseymortier, D Hudry, et al.
BMC Medical Informatics and Decision Making|June 26, 2020
GUIP1: a R package for dose escalation strategies in phase I cancer clinical trialsD Dinart, J Fraisse, D Tosi, et al.
Blood|December 1, 1993
Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 GroupP Fenaux, M C Le Deley, S Castaigne, et al.
Gynecologic Oncology|June 2, 2016
Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancerS Gouy, G Ferron, O Glehen, et al.
Pageof 3